Supreme Court to review $21M verdict for NH woman injured by generic drug
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.
LATEST NEW HAMPSHIRE ANGLE
Marijuana seller target of robbery
Fosters: It’s too soon for the happy dance
Dunbarton egg farm denial brings lawsuit